
Oncology NEWS International
- Oncology NEWS International Vol 16 No 7
 - Volume 16
 - Issue 7
 
Pilot Study Begins for NCI's Proposed NCCCP at 14 Sites
The National Cancer Institute (NCI) has initiated a 3-year pilot study for its National Community Cancer Center Program (NCCCP) to explore issues surrounding the effective delivery of cancer care at the local level.
BETHESDA, MarylandThe National Cancer Institute (NCI) has initiated a 3-year pilot study for its National Community Cancer Center Program (NCCCP) to explore issues surrounding the effective delivery of cancer care at the local level. The 14 participating sites will share $5 million annually. An independent contractor will evaluate their efforts, and at the end of the study, NCI and outside experts will make recommendations about expanding the NCCCP concept nationwide. "The goal of this project is to identify the critical factors that define a state-of-the-art community cancer center," NCI director John E. Niederhuber, MD, said at a meeting of the National Cancer Advisory Board.
The participants are: the Billings Clinic, Montana; Hartford Hospital, Connecticut; St. Joseph's/Candler, Savannah; Our Lady of the Lake Regional Medical Center, Baton Rouge; Sanford USD Medical Center, Sioux Falls, South Dakota; Spartanburg Regional Hospital, South Carolina; St. Joseph Hospital, Orange, California; Christiana Hospital, Newark, Delaware; St.Vincent Indianapolis Hospital; Columbia St. Mary's, Milwaukee; Brackenridge Hospital, Austin, Texas; Penrose-St. Francis Health Services, Colorado Springs; St. Joseph Medical Center, Towson, Maryland; and a coordinated site of three Nebraska hospitals: Good Samaritan, Kearney; St. Elizabeth Regional Medical Center, Lincoln; and St. Francis Medical Center, Grand Island.
Articles in this issue
over 18 years ago
Education Plan Promotes Use of Evidence-Based Practiceover 18 years ago
New Antiangiogenesis Agent Promising in Glioblastomaover 18 years ago
SearchMedica Oncology Debuts at ASCOover 18 years ago
New Small Molecule TKI Active in Thyroid Cancerover 18 years ago
NCI Rejects NSABP's P-4 Prevention Trialover 18 years ago
Trustee Warns That Medicare Is Heading for Insolvencyover 18 years ago
Experts Push for Trials of Statins to Prevent Prostate Caover 18 years ago
First-Line Dasatinib Effective in Chronic Phase CMLover 18 years ago
Vascular Disrupting Agent NPI-2358 in Phase I StudyNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.



















































































